Ilika Q&A: At an exciting point in scaling up the Stereax technology (LON:IKA)

stereax

Ilika plc (LON:IKA) Chief Executive Officer Graeme Purdy caught up with DirectorsTalk for an exclusive interview to discuss how Stereax batteries are made, the pilot line operation, key factors that resulted in outfitting and operating its own facility and the timeline involved.

Q1: Update this morning regarding Ilika’s is manufacturing plans for Stereax, could you just briefly describe the process for making these batteries?

A1: Our Stereax batteries are miniature batteries which are used to power miniature medical devices and internet of things for industry so wireless sensors in hostile environments in particular. These batteries are made on wafers and they’re deposited in a vacuum deposition process, similar to the processes that are used by the MEMS industry to make sensors and actuators. Once we’ve deposited the active materials onto the wafers, then they’re processed using microfabrication techniques which effectively allow us to pattern the wafers and make the individual devices.

Q2: Can you recap on the status of your pilot line operation then?

A2: So, at the moment, these Stereax miniature cells are made on a pilot line that is located in facilities which are within the university of Southampton here in the UK. We are at the point where the utilisation of that pilot line for commercial sales has justified us raising the capital to invest in a manufacturing facility. So, we’re at an exciting point in scaling up that technology.

Q3: Now, you previously talked about having a third party facility or fab run the scale-up  process for you. What sort of fabs did you consider?

A3: We’ve looked at mid-sized fabs around the world, most of the suitable facilities would either be in North America or Europe, typically historically semiconductor fabs which are designed to run a six inch or maybe eight inch wafers. Most recently, most of them have specialised in producing MEMS devices, these sensors.

Actually, we’ve compared these facilities with the option of the company outfitting its own facility close to our current operating base here in Southampton.

Q4: And you’ve decided now to outfit your own operating facility, what were the key factors that resulted in this?

A4: Well, when we’ve looked at these different options, we’ve always wanted to maximise the return on investment that we’re making, it’s quite a sizeable investment, about £4 million  relative to the size of the company, and we want to make sure that we get this right.

So, we’ve always looked for the route that gets us to market quickest, what’s the option that has the quickest route to product launch and also, increasingly actually over the past year, we’ve become sensitive to control of our own implementation timelines and operations without having to worry about any restrictions or other priorities that a third party might have.

Ultimately, we’ve been very sensitive to ensuring that we’ve got an attractive operating margin at volume production to ensure that we’ve got profitable products that we bring to market. In terms of managing the risk of the implementation, we’ve always wanted to make sure that we’ve got sufficient access to the expertise that we’ve got in the core technical team.

Q5: Now, you’ve said that time is a factor, what is the implementation status and the timeline involved?

A5: The key pieces of equipment that Ilika need to implement this process are on order, one of the key bits of equipment is coming from the US and one of them is coming from Switzerland.

Fabrication of these equipment items is on track and we’re looking to outfit the facility that we’ve selected in Q1 of next year so that by the time we get into Q2, we can take delivery of these equipment items, commission them, put them through their initial process qualification and then start our product qualification process.

So, we’re very much looking forward to the seventy-fold increase in productivity that we can expect from this implementation by the time we get to the end of 2021.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika plc reaches a commercial turning point as new markets emerge for Stereax and Goliath (video)

Dr Tom McColm of Morphose Capital Partners explains why the company may be approaching an important commercial inflection point.

Ilika plc: Stereax Revenue Arrives as Goliath Draws Defence Interest (video)

Ilika plc CEO Graeme Purdy outlines how Stereax has started generating product-related revenue, why M300 battery deliveries remain on track and how Goliath’s 10Ah prototype is opening new opportunities in defence and sovereign battery supply.

Ilika builds commercial momentum across Stereax and Goliath batteries

Ilika Plc reports annual results for the year ended 30 April 2026, highlighting progress on its Stereax medical battery line and Goliath large-format batteries for EV, defence and consumer applications. The company began Stereax production and deliveries, shipped larger Goliath prototypes, secured further grant funding and raised £5 million post-period to accelerate commercialisation.

Defence demand puts specialist battery technology in focus

Defence applications are increasing the need for specialist batteries that can deliver reliable power in demanding operating conditions.

Battery & Energy Storage Tech Europe 2026 targets the next phase of industrial growth

Battery & Energy Storage Tech Europe 2026 will focus on financing, deployment, manufacturing, recycling and regulation across Europe’s battery market.

Ilika moves Goliath cells into independent commercial testing

Ilika has moved its UK-made Goliath cells into independent testing as it targets commercial opportunities in automotive, defence and e-bike markets.

Search